Dashboard
Manage Tickers

DARE Dare Bioscience, Inc.

Nasdaq darebioscience.com


$ 1.99 $ -0.09 (-4.55 %)    

Thursday, 13-Nov-2025 17:22:19 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 608.59 $ -9.26 (-1.5 %)
DIA $ 475.50 $ -6.59 (-1.37 %)
SPY $ 672.57 $ -8.41 (-1.24 %)
TLT $ 89.38 $ -0.42 (-0.46 %)
GLD $ 384.40 $ -4.31 (-1.11 %)
$ 1.89
$ 2.00
$ 1.88 x 1
$ 2.11 x 49
-- - --
$ 1.76 - $ 9.19
162,955
na
27.01M
$ 1.32
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-13-2025 03-31-2025 10-Q
4 03-31-2025 12-31-2024 10-K
5 11-14-2024 09-30-2024 10-Q
6 08-12-2024 06-30-2024 10-Q
7 05-14-2024 03-31-2024 10-Q
8 03-28-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-30-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-12-2022 03-31-2022 10-Q
16 03-31-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-13-2021 03-31-2021 10-Q
20 03-30-2021 12-31-2020 10-K
21 11-12-2020 09-30-2020 10-Q
22 08-12-2020 06-30-2020 10-Q
23 05-14-2020 03-31-2020 10-Q
24 03-27-2020 12-31-2019 10-K
25 11-12-2019 09-30-2019 10-Q
26 08-14-2019 06-30-2019 10-Q
27 05-14-2019 03-31-2019 10-Q
28 04-01-2019 12-31-2018 10-K
29 11-13-2018 09-30-2018 10-Q
30 08-13-2018 06-30-2018 10-Q
31 05-14-2018 03-31-2018 10-Q
32 03-28-2018 12-31-2017 10-K
33 11-13-2017 09-30-2017 10-Q
34 08-14-2017 06-30-2017 10-Q
35 05-12-2017 03-31-2017 10-Q
36 03-31-2017 12-31-2016 10-K
37 11-03-2016 09-30-2016 10-Q
38 08-04-2016 06-30-2016 10-Q
39 05-02-2016 03-31-2016 10-Q
40 03-10-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

dare-bioscience-q3-eps-028-beats-039-estimate-sales-2262k-miss-9750k-estimate
Dare Bioscience Q3 EPS $(0.28) Beats $(0.3...
11/13/2025 21:02:38

Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.3...

earnings-scheduled-for-november-13-2025
Earnings Scheduled For November 13, 2025
11/13/2025 11:11:32

what-to-expect-from-dare-biosciences-earnings
What to Expect from Dare Bioscience's Earn...
11/12/2025 17:03:21

dar-bioscience--to-host-webinar-titled-the-dare-to-play-difference-on-nov-17
Daré Bioscience To Host Webinar Titled 'T...
11/11/2025 13:05:34

dar-bioscience-secures-gates-foundation-contract-worth-up-to-300k-to-conduct-a-strategic-landscape-review-of-organizations-with-capabilities-relevant-to-contraceptive-product-development
Daré Bioscience Secures Gates Foundation C...
11/03/2025 13:14:38

Daré Bioscience, Inc. (NASDAQ:DARE), a purpose-driven health biotech company solely focused on closing the gap in women's h...

dar-bioscience-secures-up-to-499k-from-gates-foundation-to-support-preeclampsia-research-through-mentorship-and-project-management
Daré Bioscience Secures Up To ~$499K From ...
09/24/2025 12:04:30

Daré Bioscience, Inc. (NASDAQ:DARE), a biopharmaceutical company with a sole focus of closing the gap in women's health bet...

this-brinker-international-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday
This Brinker International Analyst Turns B...
09/04/2025 14:05:42

maxim-group-upgrades-dare-bioscience-to-buy-announces-8-price-target
Maxim Group Upgrades Dare Bioscience to Bu...
09/04/2025 12:12:14

Maxim Group analyst Caroline Palomeque upgrades Dare Bioscience (NASDAQ:DARE) from Hold to Buy and announces $8 price target.

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/14/2025 21:06:20

dare-bioscience-q2-eps-045-beats-061-estimate
Dare Bioscience Q2 EPS $(0.45) Beats $(0.6...
08/14/2025 20:03:54

Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.6...

Core News & Articles
Earnings Scheduled For August 14, 2025
08/14/2025 08:32:32

a-preview-of-dare-biosciences-earnings
A Preview Of Dare Bioscience's Earnings
08/13/2025 16:02:55

dar-bioscience-launch-phase-one-of-patient-focused-campaign-with-rosy-wellness-to-support-dare-to-play-sildenafil-cream
Daré Bioscience Launch Phase One Of Patien...
07/29/2025 12:05:11

A first-of-its-kind solution for women's arousal in a proprietary topical formulation demonstrated to work where women need...

us-stocks-end-higher-amid-tariff-concerns-investor-sentiment-improves-fear--greed-index-remains-in-extreme-greed-zone
US Stocks End Higher Amid Tariff Concerns:...
07/15/2025 06:48:23

crude-oil-moves-lower-dar-bioscience-shares-jump
Crude Oil Moves Lower; Daré Bioscience Sha...
07/14/2025 17:09:18

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
07/14/2025 17:06:03

us-stocks-edge-lower-fastenal-posts-upbeat-earnings
US Stocks Edge Lower; Fastenal Posts Upbea...
07/14/2025 13:49:29

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
07/14/2025 12:08:12

dar-bioscience-reports-interim-phase-3-results-from-ongoing-phase-3-clinical-trial-evaluating-contraceptive-effectiveness-safety-and-acceptability-of-ovaprene
Daré Bioscience Reports Interim Phase 3 Re...
07/14/2025 12:05:52

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
07/11/2025 12:07:13

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION